Beta Bionics, Inc. Common Stock BBNX Income Statement
| FY'25 | FY'24 | ||
|---|---|---|---|
| $100.25M+53.9% | $65.12M+443% | ||
| $44.71M+52.9% | $29.24M+414% | ||
| $55.54M+54.8% | $35.89M+469% | ||
| 55.4%+0.3pp | 55.1%+2.5pp | ||
| $34.79M+32.9% | $26.18M+45.9% | ||
| $61.4M+65.6% | $37.09M+209% | ||
| $31.03M+73.6% | $17.87M+46.2% | ||
| $127.22M+56.8% | $81.14M+92.5% | ||
| $127.22M+56.8% | $81.14M+92.5% | ||
| -$71.68M-58.4% | -$45.25M-26.2% | ||
| -71.5%-2.0pp | -69.5%+229pp | ||
| $10.93M+180% | $3.91M+120% | ||
| —— | -$9.51M-15.2% | ||
| -$73.2M-33.7% | -$54.76M-24.2% | ||
| -73%+11.1pp | -84.1%+284pp | ||
| -$1.94+77.5% | -$8.64-4.0% | ||
| -$1.94+77.5% | -$8.64-4.0% | ||
| 158.3M+529% | 25.2M— | ||
| 158.3M+529% | 25.2M— | ||
| -$72.86M-32.9% | -$54.83M-24.7% | ||
| $338K+528% | -$79K-158% | ||
| $100.25M+53.9% | $65.12M+443% | ||
| -$71.68M-58.4% | -$45.25M-26.2% | ||
| -$70.11M-59.0% | -$44.1M-27.4% | ||
| -$70.11M-59.0% | -$44.1M-27.4% | ||
| -69.9%-2.2pp | -67.7%+221pp | ||
| -$71.68M-58.4% | -$45.25M-26.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Beta Bionics, Inc. Common Stock's revenue?
- Beta Bionics, Inc. Common Stock (BBNX) generated $110.2M in revenue over the trailing twelve months, up 57.9% year over year.
- Is Beta Bionics, Inc. Common Stock profitable?
- Beta Bionics, Inc. Common Stock is not currently profitable: it reported a net loss of $66.4M over the trailing twelve months, a -60.3% net margin.
- What are Beta Bionics, Inc. Common Stock's profit margins?
- Gross margin is 57.2% and operating margin is -70.1%, with a -60.3% net margin.
- What is Beta Bionics, Inc. Common Stock's earnings per share?
- Beta Bionics, Inc. Common Stock's diluted EPS over the trailing twelve months is $-1.50.
- Where does Beta Bionics, Inc. Common Stock's income statement data come from?
- Every line is extracted from Beta Bionics, Inc. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
